.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Final results from the Phase 3 ClarIDHy trial
Lively expert panel discussions featuring peer-to-peer exchanges
Long-term efficacy and safety of TRK fusion-positive lung cancer treatment

SpecialtySee All >

Biosimilars
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Head & Neck Cancers
Hematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma

Advertise
About OncLive
Editorial Board
CureToday.com
TargetedOnc.com
CancerNetwork.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Modern-Day Treatment of Chemotherapy-Induced Nausea and Vomiting

EP. 1: Importance of Proactive CINV Management

August 3rd 2015

EP. 2: Understanding the Types and Causes of CINV

August 3rd 2015

EP. 3: Available Treatment Options for CINV

August 3rd 2015

EP. 4: Role of the Pharmacist in CINV Treatment

August 3rd 2015

EP. 5: Educating Patients About CINV

August 3rd 2015

EP. 6: Netupitant Plus Palonosetron for CINV Prevention

August 3rd 2015

EP. 7: Guidelines for CINV Prophylaxis and Treatment

August 3rd 2015

EP. 8: Cost and Quality Considerations in CINV Management

August 3rd 2015

EP. 9: Future Directions in the Management of CINV

August 3rd 2015

EP. 10: Remaining Challenges in CINV Treatment

August 3rd 2015